Starpharma Holdings Ltd

PQ6

Company Profile

  • Business description

    Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

  • Contact

    4-6 Southampton Crescent
    Abbotsford
    MelbourneVIC3067
    AUS

    T: +61 385322700

    https://www.starpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    32

Stocks News & Analysis

stocks

3 "buy the dip" candidates with wide moats

Share price pullbacks can present an opportunity to buy high quality companies at attractive prices.
stocks

Undervalued ASX share hampered by delays in foreign expansion

A near monopoly in Australia pushes this company into global markets but progress has been slow.
stocks

Ask the analyst: Why has MinRes fallen so far?

Mineral Resources shares are down almost 50% year to date. Mark Taylor weighs in on some of the reasons why.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,515.203.70-0.04%
CAC 407,340.6086.28-1.16%
DAX 4019,227.22221.38-1.14%
Dow JONES (US)44,293.13304.140.69%
FTSE 1008,080.4944.70-0.55%
HKSE19,846.88580.05-2.84%
NASDAQ19,298.7611.990.06%
Nikkei 22539,376.09157.23-0.40%
NZX 50 Index12,749.3663.030.50%
S&P 5006,001.355.810.10%
S&P/ASX 2008,255.6010.60-0.13%
SSE Composite Index3,421.9748.10-1.39%

Market Movers